CEQUA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 11 Feb 2026)
What this means for you
Registered since 21 Jan 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jan 2030: the §8 & §9 renewal).
Record
- Serial number
- 87718043
- Registration number
- 5967994
- Mark type
- Word mark
- Filed
- 12 Dec 2017
- Published for opposition
- 24 Apr 2018
- Registered
- 21 Jan 2020
- Next maintenance filing
- §8 & §9 renewal, due by 21 Jan 2030 (grace period to 21 Jul 2030)
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Ocular pharmaceuticals; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders; eye drops containing pharmaceutical compositions for treatment of ocular disorders; topical ophthalmic pharmaceutical products for the treatment of dryness of the eye
Owner
- SUN PHARMACEUTICAL INDUSTRIES LIMITED, VADODARA, GUJARAT, IN
- Sun Pharma Global FZE, Dubai, AE
- Sun Pharma Global FZE, Dubai, AE
- Sun Pharma Global FZE, Dubai, AE
Prosecution history
- 11 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 Feb 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Nov 2025 — TEAS SECTION 8 & 15 RECEIVED
- 21 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Nov 2019 — USE AMENDMENT FILED
- 01 Dec 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Nov 2019 — TEAS STATEMENT OF USE RECEIVED
- 21 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jun 2019 — SOU EXTENSION 2 GRANTED